Midterm Flashcards
origin of the word pharmacology
greek
pharmakon = remedy
logos = study
what is pharmacology?
the study of drugs
includes how it is delivered, how it works, the therapeutic effects and adverse effects
classification of therapeutics
drugs - traditional drugs i.e. chemical agents
biologics - ie antibodies, hormones
natural health products - i.e. herbals, vitamins, minerals `
Describe the levels of Canadian Drug Legislation
Food and Drugs Act and Regulations
then Health Canada
then Health Canada Products & Food Branch
then
Therapeutic Products Directorate (traditional drugs)
Biologics and Genetic Therapies Directorate (abs, hormones)
Natural Health Products Directorate (vitamins, herbals etc)
3 types of drug names
chemical name
generic name
trade name
chemical name
describes the chemical structure of the molecule
used by chemists
generic name
a unique name that identifies a drug
most often used in pharmacology and should be used by health care professionals
trade name
assigned by a drug company
easy to remember and marketable
many companies make the same drug so there can be many trade names for the same drug
steps of approval of marketed drugs in Canada
preclinical testing clinical trial application phase I clinical trial phase II clinical trial phase III clinical trial new drug submission submitted to health Canada phase IV clinical trial
about 15 years total, up to $800 million
preclinical testing
also called discovery
in cultured cells, living tissue or experimental animals
evaluate biological effects, pharmacokinetics and toxicity
about 6.5 years
clinical trial application
paperwork detailing all pre-clinical data must be submitted to Health Canada before any human studies
they will respond within 30 days of receipt
phase I clinical trial
20-100 HEALTHY volunteers
evaluation of pharmacokinetics and pharmacodynamics
about 1 year
phase II clinical trial
300-500 PATIENTS with the target disorder
therapeutic effectiveness, side effects, and dosing information gathered
about 2 years
phase III clinical trial
500-5000 patients with the target disorder
therapeutic effectiveness verified, long-term side effects assessed
about 4 years
new drug submission (NDS)
NDS submitted to Health Canada
a report that details therapeutic effectiveness and safety
includes results from pre-clinical and clinical studies
about 1.5 years
if a NDS is approved what happens?
Health Canada issus a Notice of Compliance (NOC) and a Drug Information Number (DIN)
both are required to market the drug
phase IV clinical trial
post-marketing surveillance
Health Canada monitors the efficacy and safety of the drug after it has been marketed (can be pulled i.e. vioxx)
what is pharmacokinetics?
study of drug movement in the body
what the body does to a drug
includes absorption, distribution, metabolism and excretion
when an oral drug is absorbed and goes to the liver what are the 2 options it has?
can enter systemic circulation and go to heart, brain, muscle, kidney etc
or
can enter the bile duct and be excreted into the intestine
when a drug is parenteral where does it go?
absorbed right into systemic circulation
physiological barriers to drug transport
intestinal villi
tight junctions between cells
what happens in the SER?
metabolizes drugs, carbs and steroids
what happens in the golgi?
processes and packages proteins and lipids
why is the cell membrane fluid?
phospholipids are flexible and undulate
3 ways drugs pass through cell membranes
direct penetration
ion channels and pores
transporters
what molecules go through ion channels and pores?
MW <200 (i.e. very small compounds)
examples: Na, K, Li
uptake transporters
move drugs from outside cell to inside cell
mediate intestinal absorption, renal excretion and reaching target sites
efflux tranporters
move drugs from inside cell to outside
protect cells
are found in the intestine, placenta, kidney and BBB
polar drugs
uneven distribution of charge but no net charge
ie kanamycin
ion drugs
total # of electrons is not equal to protons
have a net charge
ie Na+, Li+ etc
quaternary ammonium compounds
at least one N atom and always have a positive charge
cannot cross cell membranes bc of this charge
when can weak acids and bases cross cell membranes?
when un-ionized
ie weak acid in acidic environment or weak base in basic environment
how do drugs move out of capillaries?
hydrophilic drugs pass between fenestrations
lipophilic drugs either pass between fenestrations or directly through PM of endothelial cells
except in the BBB where there are no fenestrations, there are tight junction - drugs either need to be lipophilic or have a transporter to get into brain
absorption
movement of drug from site of administration into the blood
rate of it determines how quickly drug effect will occur
and the amount of it determines how intense the effect will be
6 factors affecting drug absorption
rate of dissolution surface area blood flow lipid solubility pH partitioning activity of transport proteins
how does rate of dissolution affect drug absorption?
drugs need to dissolve before they can be absorbed
faster dissolution = faster onset of action
surface area and drug absorption
larger surface area = faster absorption
this is why there is more absorption in the intestine than stomach (villi vs rugae)
blood flow and drug absorption
absorption is fastest in areas with high blood flow
high blood flow maintains a concentration gradient to drive absorption
exercises increases blood flow
heart failure, severe hypotension, hypothermia and circulatory shock decrease blood flow
lipid solubility and drug absorption
high lipid solubility are absorbed more rapidly
pH partitioning and drug absorption
absorption is greater when theres a difference between pH at the site of administration and the blood such that the drug is ionized in the blood
activity of drug transporters and absorption
uptake transporters increase absorption
efflux decrease it
major routes of drug administration
ENTERAL
- oral
- rectal
PARENTERAL
- intravenous
- intramuscular
- subcutaneous
OTHER
- sublingual
- transdermal
- pulmonary
advantages and disadvantages of oral drugs
safety, convenience, economical
incomplete and variable absorption
are weak acids absorbed better in the stomach or intestine?
intestine - stomach has thick layer of mucus and small surface area so even though they’d be unionized aren’t absorbed better here
pharmaceutical phase
what occurs after an oral tablet is taken
includes the disintegration phase into granules and smaller particles and the dissolution phase
gastric emptying and drug absorption
increasing gastric emptying increases drug absorption because it puts drugs into the intestine where more absorption occurs
increasing gastric emptying
taking meds on an empty stomach
taking meds with cold water
lying down on the right side
high osmolality feeding (i.e. feeding tube)
taking a pro kinetic drug (increases GI motility)
decreasing gastric emptying
high fat meal
heavy exercise
lying down on the left side
taking drug that inhibits vagus nerve (i.e. anticholinergics)
enteric coating
special coating that prevents drugs from dissolving in the acidic environment of the stomach
coating will dissolve once in the intestine
bioavailability
fraction of drug that reaches systemic circulation unchanged
influenced by drug formulation, route of administration and degree of metabolism
bioavailability by drug formulation, lowest to highest
time release capsules enteric coated compressed tablets capsules granules chewable (no disintegration) suspension syrup (no disintegration or dissolution) aqueous solution
sublingual drug delivery
put under tongue, dissolves and is absorbed across oral mucosa
venous drainage from oral mucosa is to the superior vena cava to heart
avoid first pass metabolism
need to be lipophilic and uncharged
is especially convenient for drugs that act on the heart
transdermal drug delivery
need to be lipophilic enough to penetrate epidermis
also need to be relatively hydrophilic to dissolve in ECF
<600 Da
usually sprays, ointments, patches etc
provide constant plasma levels (i.e. minimal troughs and peaks)
tolerance may develop unless there is a drug free period (i.e. take patch off for 6-10 hours a day)
what affects transdermal drug absorption
thickness of skin
hydration
number of hair follicles (give a way to bypass the epidermis barrier)
application area
integrity of the barrier (i.e. psoriasis, burned skin etc increases absorption)
rectal drug absorption
useful when unconscious or vomiting
approx 50% bypasses the liver
given as a suppository which dissolves, crosses the rectal mucosa into the blood
disadvantages include incomplete absorption and some drugs may irritate the rectal mucosa
IV drug absorption
directly into peripheral vein, usually back of the hand or median cubital vein at the elbow (any visible can be used though)
IV bolus or drip
if it is a drip, usually diluted in a vehicle i.e. saline
advantages of IV drug absorption
no barriers, 100% bioavailability
precise control of dosage and duration of action
can administer poorly soluble drugs that need to be diluted in a large volume
can inject drugs that are irritants slowly so they are diluted in blood
disadvantages of IV drug absorption
expensive invasive inconvenient drug cannot be removed once injected risk of infection and fluid overload risk of injecting wrong formulation i.e. giving IM by IV
subcutaneous drug absorption
under skin into subcutaneous tissue
only barrier to absorption is the capillary wall
cannot inject irritants - will cause pain and/or tissue sloughing
primary determinants of rate of absorption are blood flow and water solubility (need to be water soluble to dissolve in ECF)
intramuscular drug absorption
injected into muscle tissue
absorption determined by ability of drug to pass through fenestrations in capillary wall
primary determinants of rate of absorption are blood flow and water solubility
advantages of IM
can be used for poorly soluble drugs
can administer depot preparations
disadvantages of IM
pain/discomfort
can cause local tissue and/or nerve damage if not done properly
how does blood flow affect IM drug absorption
deltoid > vastus lateralis > gluteal
exercises increases
heart failure, severe hypotension, hypothermia decrease
pulmonary drug absorption
gaseous and volatile drugs can be inhaled and absorbed through pulmonary epithelium
very rapid absorption bc there is a large surface area
good for pulmonary disease drugs i.e. for asthma bc they are delivered to site of action
often used for general anaesthetics
what drugs distribute to the interstitial space?
low MW, water soluble
what drugs distribute to the plasma?
strongly bound to proteins, high MW
what drugs distribute to adipose tissue?
lipid soluble
where else do some drug distribute?
muscle
bone - absorb onto the crystal surface and eventually get incorporated in, can be a reservoir for slow release of some drugs
what determines drug distribution? how does this affect blood concentration?
blood flow to tissues
ability to move out of capillaries
ability to move into cells
more distributes = less in the blood
blood flow and drug distribution
well perfused i.e. liver, kidney, brain = rapid distribution
lower blood flow i.e. skin, fat, bone = slow
examples of altered blood flow
neonates have limited blood flow
heart failure or shock
solid tumors have low regional blood flow (decreases towards middle)
abscesses have no blood supply (need to drain)
P-glycoprotein
efflux transporter
protective
facilitates drug excretion and protects body from exposure to drugs and other toxins
active (needs ATP), against concentration gradient
in heptocytes on the bile canicular membrane - excrete in bile
in enterocytes on apical side - prevent absorption into blood
in proximal tubule cells on luminal side - excretion
in neuronal cells on blood vessel side - keep drugs away from brain
albumin
high affinity for lipophilic and anionic (weak acids)
malnutrition, trauma, aging, liver and kidney disease decrease plasma albumin
this increases free drug concentration, can cause toxicity
alpha 1 acid glycoprotein
primarily binds cationic (weak bases) and hydrophilic drugs
aging, trauma, and hepatic inflammation (ie hepatitis) increase plasma alpha 1 acid glycoprotein
decreases free drug concentration, can lead to ineffective therapy
Vd for drugs with low, intermediate and high Vds
low = 0.057 L/kg
intermediate -= 0.2 L/kg
high = >0.2 L/kg
volume of distribution
apparent volume that a drug distributes into
Vd = D/C (total amount/plasma concentration)
plasma
4 L
interstitial fluid
10 L
intracellular fluid
28 L
drugs with small Vd
remain in the capillaries
highly protein bound
large molecular weight (can’t get through fenestrations)
can’t leave the plasma
Vd is about 0.057L/kg
drugs with intermediate Vd
low molecular weight (can go through fenestrations) very hydrophilic (can't go through PM) intermediate protein binding
can leave plasma and enter interstitial fluid, but can’t go into cells
Vd is about 0.2 L/kg
drugs with large Vd
low molecular weight
lipophilic
minimal protein binding
can leave vascular space and interstitial fluid and go into fat, bone, muscle etc (i.e. into intracellular fluid)
Vd >0.2 L/kg
what happens if small Vd drug is displaced from proteins
does NOT distribute to tissue, stays in plasma so free drug concentration increases
what happens if large Vd drug is displaced from proteins
distributes into tissues, total plasma drug concentration decreases and apparent Vd increases further
how does body composition affect drug distribution?
elderly ppl have increased fat mass
- > drugs that distribute into fat will have larger Vd in elderly or obese ppl
- > drugs that distribute into muscle will have lower Vd in elderly (less muscle mass)
what is metabolism and where does it occur
enzyme-mediated alteration of a drug’s structure
also called biotransformation
liver- primary site intestine - enterocytes can metabolize drugs stomach - alcohol metabolism kidney intestinal bacteria
5 possible therapeutic consequences of drug metabolism
1) increase water solubility to promote excretion
2) inactivate drugs
3) increase drug effectiveness
4) activate prodrugs
5) increase drug toxicity
first order kinetics
most drugs
concentration of drug is much lower than the metabolic capacity of body (i.e. less drug than enzymes)
drug metabolism is directly proportional to the concentration of free drug
constant fraction metabolized per unit time
zero order kinetics
ie ethanol
plasma drug concentration is much higher than metabolic capacity of the body
drug metabolism is constant over time i.e. constant amount is metabolized per unit time
metabolism is independent of drug concentration
where can drugs taken orally undergo first pass metabolism and what is the result
hepatocytes in liver
enterocytes in intestine
stomach
intestinal bacteria
result is decreased parent drug in the systemic circulation
extraction ratio
depends on how much metabolism occurs on the first pass through the liver
high ER = lots of first pass metabolism
can greatly determine bioavailability
high ER drugs
low oral bioavailability (1-20%
PO doses higher than IV doses to compensate
small changes in hepatic enzyme activity produce large changes in bioavailability
very susceptible to drug-drug interactions
low ER drugs
high oral bioavailability (>80%)
PO doses similar to IV doses
small changes in hepatic enzyme have little effect on bioavailability
not very susceptible to drug-drug interactions
may pass through liver via systemic circulation multiple times before completely metabolized
phase I drug metabolism
lipophilic to more polar by introducing or unmasking polar functional groups (i.e. OH, NH2)
involved oxidation, reduction, hydrolysis
CYP enzymes, esterases and dehydrogenases
metabolites can be more active, less active or equally active as parent drug
occurs in SER
phase II drug metabolism
increase polarity of lipophilic by conjugation of large water soluble molecules to drug
ie glucuronic acid, sulphate, acetate, amino acids
metabolites are less active than the parent drug
** exception - morphine 6-glucuronide is more potent analgesic than morphine**
occurs in cytosol, except glucuronidation which is in SER
CYP enzymes
predominant phase I drug metabolizing enzymes
mostly hepatic, in SER
oxidize drugs by inserting one O atom into the drug molecule, produces water as a byproduct
12 families, 3 does most drug metabolism
(naming goes family, subfamily, isozyme)
malnutrition can decrease CYP activity as they requires dietary protein, iron, folic acid and zinc
CYP3A4 metabolizes 50% of currently marketed drugs
5 types of phase II drug metabolizing enzymes
UGTs SULTs GSTs NATs TPMT
UGTs
UDP-glucuronosyltransferases
only phase II found in SER
catalyze transfer of a glucuronic acid to a drug
once glucuronidated = more polar for easier excretion
SULTs
sulfotransferases phase II cytosolic transfer sulfate to hydroxyl of a drug more polar, easier excretion
GSTs
glutathione S transferases
phase II
cytosolic
transfer glutathione to drug (glutathione is an intracellular anti-oxidant)
putting glutathione onto a reactive drug renders the metabolite less toxic
NATs
N-acetyltransferases phase II cytosolic transfer acetyl from acetyl CoA to drug subject to polymorphisms which causes large variability in drug response
TPMT
thiopurine methyltransferase
phase II
cytosolic
transfer methyl from S-adenosylmethionine to a drug
subject to SNPs, rare but have dramatic effect
4 factors that affect drug metabolism
age
drug interactions i.e. enzyme inducers and inhibitors
disease state
SNPs
age and drug metabolism
infants have almost no CYP activity
1 year until reasonable, 2 until adult levels
elderly also have decreased levels
diseases that decrease CYP activity
liver disease
kidney disease
inflammatory diseases
infection
CYP2C9
metabolizes anticoagulant warfarin
SNPs can decrease activity
patients require lower dose of warfarin , if not get extensive bleeding